Coronavirus Vaccine: Early Data Show Moderna's Version Is 94.5% Effective

Moderna is the second company to report preliminary results from a large trial testing a vaccine. But there are still months to go before it will be widely available to the public.

from NYT > Health https://ift.tt/2UyqU4W
via health&fitness